FindTrial
Sign In

Identification of key intratumoral microorganisms in early lung adenocarcinoma and its clinical application in risk stratification of disease progression

Identification of key intratumoral microorganisms in early lung adenocarcinoma and its clinical application in risk stratification of disease progression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127179
Enrollment
Unknown
Registered
2026-06-26
Start date
2026-06-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early-stage lung adenocarcinoma

Interventions

Observation Group:None

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. 18 - 80 years old, open to both men and women; 2. Diagnosis of early-stage lung adenocarcinoma.

Exclusion criteria

Exclusion criteria: 1.Combine with other malignant tumors;

Design outcomes

Primary

MeasureTime frame
Progression-free survival;Overall survival;—

Countries

China

Contacts

Public ContactYang Haoshuai

China-Japan Friendship Hospital

yanghsh9@mail2.sysu.edu.cn+86 10 8420 6191

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026